NCT07226414

Prenatal Study in Healthy Pregnant Women

Evaluating the Impact of Perelel Prenatal on Biomarkers in Healthy Pregnant Women.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Perelel Inc. · Industry
• Sex: Female
• Age: 21 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

Clinical Trial Summary The goal of this clinical trial is to address the impact of a gummy prenatal vs a capsule based prenatal in pregnant women. The main question it aims to answer is: Does 12-week daily administration of Prenatal Capsule affect serum iron levels in pregnant women in their second trimester compared to a comparator gummy prenatal? Researchers will compare Prenatal Capsule to a comparator Prenatal Gummy to see if there are differences in serum iron levels after 12 weeks of daily use. Participants will: Take their assigned prenatal supplement (either Prenatal Capsule or the comparator Prenatal Gummy) daily for 12 weeks Be in their second trimester of pregnancy during the study period Have their serum iron levels measured at baseline and after the 12-week intervention period

Conditions

• Pregnancy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Prenatal Capsule	This study will look at the impacts of a prenatal capsule vs a gummy comparator prenatal. The prenatal consists of 2 multivitamin + micronutrient blend with one omega softgel.
DIETARY_SUPPLEMENT	Prenatal Gummy	This prenatal gummy is a commercially available multivitamin that also contains omega-3 DHA and EPA

Timeline

• Start date: 2025-12-01
• Primary completion: 2026-09-01
• Completion: 2026-11-01
• First posted: 2025-11-10
• Last updated: 2025-12-18

Locations

1 site across 1 country: United States